Abstract
Several major econometric studies have looked at mergers and acquisitions (M&As) across various industries and concluded that, in general, there is no synergy created or released by M&A activity. This investigation concentrates upon research and development (R&D) performance in the pharmaceutical industry to examine the impact of M&A activity on corporate productivity. Findings indicate that, when compared to those companies within the pharmaceutical industry that did not experience merger activity during comparable time periods, as well as to the industry as a whole, pharmaceutical companies that merged were able to achieve more favorable post-merger productivity scores than were attained prior to their merger.
Similar content being viewed by others
References
Barrett, A., Capell, K. (2002, July 29). Big pharma: Getting too big for its own good? Business Week, 74.
Bruner, R. (1999, Dec 13). M&As under scrutiny. Electronic News, 45(50): 16-19.
Comanor, W. S. (1965, May). Research and technical change in the pharmaceutical industry. The Review of Economics and Statistics, 47(2): 182-190.
Graves, S. B., Langowitz, N. S. (1993). Innovative productivity and returns to scale in the pharmaceutical industry. Strategic Management Journal, 14(3): 593-605.
Jensen, E. J. (1987). Research expenditures and the discovery of new drugs. Journal of Industrial Economics, 36: 83-95.
Koenig, M. E. D. (1992). The information environment and the productivity of research. In: H. Collier (Ed.), Recent Advances in Chemical Information (pp. 133-143). London: Royal Society of Chemistry, and In: I. K. Ravichandra Rao (Ed.) (1992), Informetrics-91: Selected Papers from the Third International Conference on Informetrics (pp. 261–288). Bangalore Sarada Ranganathan Endowment for Library Science. Also reprinted in Grimshaw, A. (Ed.) (1995), Information Culture and Business Performance (Information Strategy Report 2, prepared for the British Library by Hertis Information and Research). Hatfield, Hertfordshire, United Kingdom: University of Hertfordshire Press.
Koenig, M E. D. (1983). A bibliometric analysis of pharmaceutical research. Research Policy, 12(1): 15-36.
Koenig, M.E.D., Gans, D. J. (1975). The productivity of research effort in the U.S. pharmaceutical industry. Research Policy, 4(4): 331-349.
Lasgna, L. (1972). Research regulation and development of new pharmaceuticals: Past, present and future. American Journal of Medical Science, 263: 9-19, 67–78.
Making a meal of mergers. (1994, September 10). The Economist, 332(7880): 87-88.
McMillan, S. G., Hamilton, R. D. III. (2000). Using bibliometrics to measure firm knowledge: An analysis of the U.S. pharmaceutical industry. Technology Analysis and Strategic Management, 12(4): 465-475.
Mitchell, M. L., Lehn, K. (1990). Do bad bidders become good targets? Journal of Political Economy, 98(2): 372-398.
Narin, F., Norma, E. Perry, R. (1987). Patents as indicators of corporate technological strength. Research Policy, 16(2–4): 143-155.
Pollack, A. (2002, April 19). Despite billions for discoveries, pipeline of drugs is far from full. The New York Times: C1.
Schwartzman, D. (1976). Innovation in the Pharmaceutical Industry. Baltimore, MD: Johns Hopkins University Press.
Shliefer, A., Vishny, R. W. (1990, August 17). The takeover wave of the 1980s. Science, 249(4970): 745-749.
The trouble with mergers. (1994, September 10). The Economist, 332(7880): 13-14.
Thompson, D. E. (2001). Get big enough (but not too big) to source innovation: To grow in the high risk pharmaceutical industry, Lilly favors a collaborative strategy of ‘innovation leverage’ over an M&A approach. Research-Technology Management, 44(6): 22-26.
Vernon, J. M., Gusen, P. (1974). Technical change and firm size: The pharmaceutical industry. Review of Economics and Statistics, 56: 294-302.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koenig, M., Mezick, E. Impact of mergers & acquisitions on research productivity within the pharmaceutical industry. Scientometrics 59, 157–169 (2004). https://doi.org/10.1023/B:SCIE.0000013304.40957.0d
Issue Date:
DOI: https://doi.org/10.1023/B:SCIE.0000013304.40957.0d